Verastem reported $63.95M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
AstraZeneca AZN:LN 395649.11M 43092.62M
Curis CRIS:US $ 34.01M 15.54M
Cytokinetics CYTK:US $ 93.63M 21.79M
Epizyme EPZM:US $ 71.07M 6.36M
Gilead Sciences GILD:US $ 7000M 2704M
Immunogen IMGN:US $ 373.87M 63.79M
Laboratory Of America LH:US $ 1068.8M 164.7M
Novartis NOVN:VX SF 3625M 10227M
Tg Therapeutics TGTX:US $ 231.79M 46.11M
Verastem VSTM:US $ 63.95M 17.26M
YTE INCY:US $ 2435.38M 178.62M
Ziopharm Oncology ZIOP:US $ 60.01M 8.24M